We observed no strong positive correlations for lung adenocarcinoma, providing evidence that the transcriptional effects of mutations in KRAS, EGFR, MET, NTRK1, and PIK3CA are distinct from each other (Fig. 5). Here, KRAS is linked to lung adenocarcinoma.